Piramal Enterprises Limited — Important, 13-01-2025: Updates

Life Healthcare Group Holdings has entered into binding agreements to sell Life Molecular Imaging Limited, part of the Imaging Group previously owned by Piramal Enterprises. This development could lead to Piramal receiving an estimated USD 140 million contingent on the transaction's completion, expected in FY 2026. Furthermore, Piramal may earn additional amounts, up to USD 200 million, based on future profits tied to the Imaging Group. This potential financial influx could positively impact Piramal’s liquidity and growth prospects in the coming years. Investors should observe how these developments unfold, as they present both a significant opportunity for revenue generation and potential volatility tied to future earnings.